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Abstract
Background: Loss-of-function mutations in methyl-CpG-binding protein 2 (MECP2; MIM *300005) results in the Rett
syndrome, whereas gain-of-function mutations are associated with the MECP2 duplication syndrome.
Methods: We did research on a family with two brothers showing Xq28 duplication syndrome using various
molecular cytogenetic techniques such as multiplex ligation-dependent probe amplification and array-based
genomic hybridization.
Results: The duplicated region had several genes including MECP2 and interleukin-1 receptor associated kinase 1
(IRAK1; MIM *300283). MECP2 and IRAK1 were associated with the neurological phenotypes in dose-sensitive and
dose-critical manner. The brothers demonstrated severe intellectual disability, autistic features, generalized hypotonia,
recurrent infections, epilepsy, choreiform movements such as hand-wringing movement, and moderate increased
spasticity with the lower limbs. The X-inactivation test showed a complete skewed X inactivation pattern of mother. In
this reason, the mother had the same loci duplication but showed significantly little neurological manifestation
compared to the two sons.
Conclusions: MECP2/IRAK1 duplication at Xq28 is inherited as an X-linked recessive trait and male-specific disorder
associated with severe intellectual disability. We tried to analyze the information of the relationship between
neuropsychiatric phenotype and the extent of duplication at Xq28 by comparing with previous reports.
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Background
X-linked intellectual disability (XLID) is found in
approximately 5–10% of the intellectually disabled men [1].
XLID is divided into syndromic forms in which intellectual
disability is one of many symptoms, and non-syndromic
forms, in which intellectual disability is the only symptom.
In a previous study, 102 genes were shown to be associated
with 81 out of 160 cases of XLID syndromes in over 50
families with non-syndromic XLID [1]. Most of the genetic
defects leading to XLID are loss-of-function mutations, in-
cluding point mutations (frame shift, nonsense, and mis-
sense), microdeletions, and translocations. XLID caused by
gain-of-function is via microduplication where causal genes
are abnormally copied. A well-known XLID microduplica-
tion region is Xq28, in which there is duplication of X-
linked genes such as methyl-CpG-binding protein 2
(MECP2; MIM *300005) a key gene involved in Rett syn-
drome, a neurodevelopmental disorder that affects mostly
girls Xq28 duplication syndrome is an important aspect of
XLID. Mutations in the MECP2 gene in Xq28 were first
reported in patients with Rett syndrome in 1999 [2] and
other X-linked severe neurodevelopmental disorders. Par-
ticularly, large deletions, single base mutations, or small
frame shift mutations in MECP2 are mostly commonly as-
sociated with Rett syndrome [3, 4]. Classical Rett syndrome
is typically characterized by a period of normal develop-
ment until 6 to 18 months of age. After this age, motor
and speak skills regress, followed by loss of useful hand
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skills; rather afflicted children exhibit repetitive hand mo-
tions, such as hand wringing. Additional symptoms of Rett
syndrome include acquired microcephaly, profound intel-
lectual disability, epilepsy, ataxia, and autistic behaviors.
There is a wide spectrum of disease severity for Rett syn-
drome as determined by molecular diagnostics [5].
While loss-of-function mutations in MECP2 result in
Rett syndrome gain-of-function mutations are associated
with MECP2 duplication syndrome. MECP2 duplications
were initially described in a female patient presenting
with a speech variant symptom and was diagnosed mo-
lecularly with atypical Rett syndrome [6]. MECP2 dupli-
cation syndrome and Rett syndrome share overlapping
clinical phenotypes include intellectual disability, motor
deficits, epilepsy, hypotonia, and progressive spasticity
[7, 8]. Males with Xq28 duplication, including duplica-
tions at the MECP2 locus spanning 0.3–4 Mb, have sub-
sequently been reported by employing the multiplex
ligation-dependent probe amplification (MLPA) and
array-based comparative genomic hybridization (array-
CGH) [7, 9–11]. Common phenotypes in males with
MECP2 duplication are severe to profound X-linked in-
tellectual disability, Rett syndromic features, progressive
spasticity, neonatal or infantile hypotonia, poor speech
development, recurrent respiratory infections, epilepsy,
and dysmorphic facial features such as large ears, mid-face
hypoplasia, brachycephaly, and depressed nasal bridge [8].
In this study we identified one family with two broth-
ers with Xq28 duplication syndrome and a mother who
was a carrier with the same loci duplication. We charac-
terized the duplicated region of the brothers and the
mother using various molecular and cytogenetic tech-
niques and to present clinical features.
Methods
Patients
A family including two sons aged 11 and 10 years old
and their mother with Xq28 duplication was researched
(Fig. 1a and Additional file 1: Figure S1). A duplication
of 411.478kb in Xq28 was identified in all three family
members using the MLPA and array-CGH.
Patient 1
Patient 1 was an 11-year-old boy who was born at 41
weeks’ gestation by spontaneous vaginal delivery. At
birth the boy weighed 2500 g, and there was no history
Fig. 1 A pedigree of the family and the results of MLPA analysis. a A pedigree of the family. b Apparently normal GTG-banded X chromosomes
of the patients. c MLPA result of the II-1 patient 1. MLPA analysis using the P015 MECP probemix showed duplications of the MECP2 and several
other genes (rectangle)
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of brain damage (Table 1). The father passed away in car
accident, and the mother was healthy and non-
consanguineous. At birth, he was treated in the neonatal
intensive care unit over three weeks due to infantile cen-
tral hypotonia with poor sucking. His feeding problems
in infancy needed to be remedied via special feeding
techniques and improved gradually with age. His devel-
opmental delay became more obvious as time went by.
Independent walking started at 36 months of age. He
was vulnerable to bacterial infections such as pneumonia
and gastroenteritis, requiring hospitalization about three
times a year. Currently, he cannot make eye contact and
social-emotional reciprocity, nor form any meaningful
words. And he have excessive adherence to the pencil,
hand stereotypes including hand shaking and hyper-
reactivity to unusual interest. He can not live a social life
without a carer.
At the time of study evaluation his height was 149 cm
(50–75th percentile), weight was 50 kg (75–90th percentile),
and occipito-frontal circumference was 53 cm (75–90th
percentile). According to the Korean-Child Development
Review (K-CDR) [12], his gross and fine motor skills
corresponded to those observed in children aged 30 and
20 months, respectively. Self-help and social levels were
equivalent to that of a 24- and 18-month-old, respectively.
Language development was at the 14-months level. He was
diagnosed with autistic spectrum disorder in accordance
with the fifth edition of the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM-V) [13]. According to the
mental developmental index of the Bayley Scales of
Infant Development test II (BSID II) [14], the equiva-
lent age of the patient was 24 months, implying se-
vere intellectual disability. Mild dysmorphic features
(brachycephaly, slightly upturned nares, and large and
low set ears) and generalized hypotonia were observed
(Fig. 2a-d). Upon neurological examination, he had
significant weakness in the extremities; based on the
Medical Research Council (MRC) for muscle strength
the patient was a grade 3 with regards to choreiform
gait movements, such as hand wringing, and moder-
ate to increased spasticity of the lower limbs.
He presented with generalized tonic-clonic type seizures
at 10 years of age. In his interictal-electroencephalogram
(EEG) there were epileptic sharp wave discharges from the
Table 1 Clinical characteristics of the patients
Patient Patient 1 Patient 2 Mother
Age 11 years 10 years 38 years
Gender Male Male Female
Prenatal history 41 weeks, 2500g, NSVD
Infantile hypotonia
41 weeks, 3000g, C/sec
Gross motor of K-CDR 30 month function 30 month function
Fine motor of K-CDR 20 month function 22 month function
Self-help level of K-CDR 24 month function 12 month function
Social level of K-CDR 18 month function 16 month function
Language development of K-CDR 14 month function 14 month function
Mental scale of BSID II 24 month function 9 month function
Motor scale of BSID II 14 month function 12 month function
K-WAIS-IV 77 (6th percentile)
Head and face Brachycephaly
Large & Low set ears





Autism or autistic features O O X
Generalized hypotonia O O X
Choreiform movements O O X
Progressice spasticity O O X
Drooling O O X
Bruxism O X X
Brain-MRI finging normal Normal None
Recurrent infecition Pneumonia and gastroenteritis Pneumonia None
Medical problem Epilepsy treated with
oxycarbamazepine
Epilepsy treated with valproate Narcolepsy treated with
modafinil and SSRI
BSID II Bayley Scales of Infant Development test II, C/sec Cesarean section, K-CDR Korean-Child Development Review, K-WAIS-IV Korean Wechsler Adult Intelligence
Scale fourth edition, NSVD normal spontaneous vaginal delivery, SSRI selective serotonin reuptake inhibitor
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right temporal cerebral area with poorly regulated poster-
ior rhythm and slow background activity (Fig. 2e). Mag-
netic resonance imaging (MRI) scan of the brain revealed
no abnormalities. At 4-year follow-up, seizures were
controlled via oxcarbazepine administration without any
side effects.
Patient 2
Patient 2 was Patient 1’s younger brother. He was 10
years old and showed severe autistic features along with
global developmental delay and intellectual disability. He
was born at 41 weeks’ gestation via cesarean section
(due to cephalopelvic disproportion) with a birth weight
of 3000 g. At the time of birth there was no history of
brain damage. Delayed development was apparent, as he
was unable to walk independently before 25 months of
age. He has had multiple bacterial infections resulting in
pneumonia, each time leading to hospitalization. He was
diagnosed with autistic spectrum disorder in the DSM-V
[14] at 8 years of age, and he has been rehabilitated ever
since.
At the time of the study his height was 139 cm (75–90th
percentile), weight was 37 kg, and head circumference was
54 cm (75–90th percentile). According to the K-CDR scale
[12], the boy’s gross and fine motor skills correlated to 30
and 22 months, respectively. His self-help, social, and lan-
guage skills corresponded to 12, 16, and 14 months of age,
respectively. According to the mental developmental
index of the BSID II [14], the age equivalent of the patient
was 9 months, suggesting severe intellectual disability.
Upon physical examination, mild dysmorphic features
(large ears, slightly upturned nares, and mid-face hypopla-
sia followed by a depressed nasal bridge) and generalized
hypotonia were noted (Fig. 2f–i). Upon neurological
examination, the profiles of Patient 1 and Patient 2 were
similar such as decreased MRC scale grade 3 with regards
to choreiform gait movements and moderate to increased
spasticity of the lower limbs.
Generalized tonic-clonic type seizures started at the
age of 10 years. In his interictal-EEG there were frequent
generalized bursts of epileptic sharp wave discharges
from both the frontal cerebral area followed by attenu-
ation of background activity (Fig. 2j). MRI of the brain
showed no abnormalities. He was initially treated with
valproic acid in order to treat his seizures. And seizures
were well controlled without any side effects for 4 years.
He has no evidence of complement deficiency 10
years old (C3: 131 C4: 16.50, and CH50: 50 mg/dL).
Fig. 2 Clinical features of patient 1 and 2. Clinical features of patient 1 (a-e). Facial dysmorphisms with brachycephaly, slightly upturned nares,
large and low set ears were observed (a, b). Axial T2 (c) and sagital T1 (d)-weighted brain MRI images were in normal limits. interictal EEG shows
epileptic sharp wave discharges from the right temporal cerebral area with poorly regulated posterior rhythm and slow background activity (e).
Clinical features of patient 2 (f-j). Facial dysmorphisms with large ears, slightly upturned nares, and midface hypoplasia followed by depressed
nasal bridge were observed (f, g). Axial T2 (h) and sagital T1 (i)-weighted brain MRI images showed no abnormalities. interictal-EEG reveals
frequent generalized burst of epileptic sharp wave discharges from the both frontal cerebral area followed by attenuation of background
activity (j)
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Immunoglobulin (Ig) levels and IgG subclass were
normal (IgM: 228, IgG2: 279, IgG3: 82, and IgG4: 10
mg/dL and IgE: 21.2 U/mL) or mildly elevated (IgG:
1970, IgA: 554, and IgG1: 1347 mg/dL). The anti-
nuclear antibody (ANA) was negative.
Currently he cannot make eye contact and facial ex-
pressions, and is unable to produce any meaningful
words. He has a strong attachment to unusual objects
such as flipping through pages of books, and he drools
excessively. He is followed with regular checkup for 4
years without seizure.
Mother
The 38-year-old mother had normal cognition but suf-
fered from psychiatric symptoms including depressive
episodes and narcolepsy with frequent cataplexy. She
sometimes collapsed when standing, or walking. She
took medicine to treat these symptoms including moda-
finil and selective serotonin reuptake inhibitor. She also
experienced abnormal menstrual cycles. At the time of
the study, her weight was 70 kg (Body Mass Index: 28.4,
> 99th percentile), and her height was 157 cm (10–25th
percentile). Her lips were prominent, and her OFC was
54 cm (25–50th percentile). Her intelligence quotient
(IQ) as measured by the Korean Wechsler Adult
Intelligence Scale fourth edition (K-WAIS-IV) [6] was
77 (6th percentile), suggesting borderline intellectual
disability. No other abnormalities were reported.
Cytogenetic analysis
For high-resolution chromosome analysis peripheral
lymphocytes were cultured by conventional thymidine
methods [15]. Cell harvests, fixations, and slide prepara-
tions were performed using a standard protocol. The
slides were stained by the GTG-banding method, and 20
metaphases were examined.
MLPA analysis
Genomic DNAs of the proband and all his family mem-
bers were extracted from peripheral blood samples using
the QuickGene-610L Nucleic Acid Isolation System
(Fujifilm Tokyo, Japan). The extracted DNAs were mea-
sured by a NanoDrop® spectrophotometer, ND-1000
(NanoDrop Technologies, Wilmington, DE). To identify
whether or not the patient had a common microdele-
tion, the MLPA was performed using the SALSA MLPA
P245 Microdeletion Syndromes-1 probemix which con-
tains probes for 23 different microdeletion syndromes
and the SALSA MLPA P015 MECP2 probemix (MRC-
Holland, Amsterdam, Netherlands). All procedures were
accomplished according to the manufacturer’s protocol.
The reaction products were loaded on an ABI Prism
3130XL automatic genetic analyzer (Applied Biosystems,
Foster City, CA) and analyzed by the GeneMaker v1.95
software (Softgenetics, State College, PA).
Array-CGH
To characterize the breakpoints and the size of the dupli-
cated region array CGH using the Cytoscan® HD array
(Affymetrix, Santa Clara, CA) was performed. All proce-
dures including DNA labeling, hybridization, and post-
hybridization washing were carried out by a commercial
service provider (BioCore, Korea) according to the manu-
facturer’s protocol. The arrays were scanned and analyzed
using the GeneChip® 3000 Scanner (Affymetrix, Santa
Clara, CA) and the Affymetrix Chromosome Analysis
Suite (ChAS) v1.2 Software, respectively.
X-inactivation test (XCI)
X chromosome inactivation pattern of the mother was
examined by the human androgen-receptor locus
(HUMARA) methylation analysis [16]. Briefly genomic
DNA was digested with methylation-sensitive restric-
tion endonuclease, HpaII and then the polymorphic
CAG repeated in the HUMARA locus was amplified
by polymerase chain reaction (PCR). Skewed XCI was
determined by the PCR product size and the inherited
pattern of the alleles.
Results
High-resolution cytogenetic analysis showed apparently
normal karyotypes in the proband and family members.
However the MLPA analysis used the P245 microdeletion
syndromes-1 probemix detected a duplication of the
MECP2 region in the proband, his older brother and
mother. These results were re-evaluated using the P015
MECP2 probemix and in addition to MECP2 gene, dupli-
cation signals for IRAK1, L1CAM and IDH3G were also
identified (Fig. 1b and c).
In the HUMARA analysis the mother was heterozygous
(302/314) and the proband was hemizygous (302) for
HUMARA locus. After HpaII digestion (only unmethy-
lated allele digested), only one allele (302) was amplified
in the mother and no amplification product was obtained
in the proband. These results indicated that XCI in the
mother was completely skewed, only the X chromosome
with duplication of the Xq28 region were inactivated in
almost all cells (Fig. 3).
Array CGH analysis confirmed the earlier MLPA results
and revealed the exact breakpoints and the size of the du-
plicated region. A gain signal at Xq28 region spanning
about 411kb was identified in both patients and their
mother (chrX:153,0027,303-153,438,781). Array CGH data
are summarized in table 2.
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Discussion
A duplication of 411.478 kb in Xq28 including the
MECP2 and IRAK1 genes, was identified in our study,
while varying sizes of 200–4000 kb have been reported
in other studies [10, 11, 17].
Xq28 duplication syndrome involving MECP2 gene is
inherited as an X-linked recessive trait associated with
severe to profound intellectual disability. Clinical mani-
festations are male-specific with symptoms such as
recurrent infections that may lead to premature death,
infantile hypotonia, mild dysmorphic features, progres-
sive spasticity of the lower limbs observed after 3 years
of age, autistic features, and generalized epilepsy [8].
These clinical features were first described as Lubs-type
X-linked mental retardation syndrome (MIM #300260)
[18], and current understanding of the genetic basis was
recognized as chromosomal duplication of the MECP2
region [19]. The function of MeCP2 as repressor or
activator of transcription, chromatin architecture, and
regulation of RNA splicing contributes to essential brain
development as a regulator of synaptic and neuronal
plasticity [20, 21]. MECP2 overexpression in mice also
present as a neurological phenotype. The mice exhib-
ited hallmark symptoms such as abnormal forepaw
movements, hypoactivity, and premature death [22].
Additionally, mice that overexpressed wild-type hu-
man MECP2 from its own promoter developed pro-
gressive seizures [22]. Interestingly enough, this study
and additional scans of the literature indicate that
epilepsy associated with MECP2 duplication syndrome
cannot be considered as a useful marker for early
diagnosis. However, epilepsy is present in >90% of
adolescent patients and shows a peculiar electro-clinical
pattern. In a recent review, Ramocki et al. reported in
>50% incidence of epilepsy in 110 patients with MECP2
duplication, resulting in severe seizures of multiple types
[8]. More than half of the patients were resistant to seizure
drug medicine, and there was also a case in which a pa-
tient was on a combination of multiple seizure drugs, and
a ketogenic diet [23]. The common interictal EEG pattern
in patients with MECP2 duplication from this study re-
vealed asynchronous waves and generalized discharge of
spikes from the fronto-temporal area with abnormal EEG
background frequency and rhythm, such as the abnormal
K complex and sleep spindle [23]. These EEG patterns
were similar to those found in other genetic syndromes,
such as 4p- syndrome or Angelman syndrome [24], thus
perhaps making diagnosis difficult. With regards to pos-
sible therapies, a previous study reported that deep brain
stimulation reduced convulsions up to 65% in case of
Fig. 3 X-inactivation analysis. (Top) The mother (I-2) is a heterozygous for HUMARA allele (302 and 314). The affected son received the 302 allele
from the mother. (Bottom) After the methylation-sensitive restriction endonuclease, HpaII digestion, the only one allele 302 (methylated, inactive)
was identified in the mother. This result represented completely skewed (100:0) inactivation of the X chromosome containing the MECP2
region duplication
Table 2 Summary of array-comparative genomic hybridization results
Chromosome region Start End Size (Kb) Gain/loss Marker count OMIM gene
Xq28 1530027303 153438781 411.478 gain 1036 PLXNB3, SRPK3, IDH3G, SSR4, PDZD4,
L1CAM, AVPR2, ARHGAP4, NAA10, RENBP,
HCFC1, TMEM187, MIR3202-1, MIR3202-2,
IRAK1, MIR718, MECP2, OPN1LW
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failed multiple anti-epileptic drugs [25]. Epilepsy is a sig-
nificant sign of MECP2 duplication syndrome, and an
EEG follow-up of these patients from early childhood
should be encouraged. Moreover, the definition of a more
specific epileptic phenotype could be useful in order to
suspect MECP2 duplication syndrome in older, undiag-
nosed patients. In our study, Patient 1 was treated with
oxcarbazepine and Patient 2 with valproic acid, and serial
follow-up interictal EEGs are needed to confirm the
clinical improvement.
MECP2 severity is linked to copy number. Del Gaudio
et al. found a MECP2 triplication in one boy resulting in
a more severe phenotype than MECP2 duplication [9].
This implies that copy number is associated with en-
hanced disease. Thus, the MECP2 gene is a dose-
sensitive and a critical gene in neurological development
and disorders. Additionally in our study, we note that
among the dysmorphic and neurological XLID pheno-
types observed in Patient 1 and 2, the influence of
MECP2 was most critical in the manifestation of these
features. Undiagnosed patients presenting with MECP2
duplication phenotypes and seizure should be tested for
MECP2 duplications via the array-CGH or MLPA, diag-
nostics that were crucial in our study.
X-linked genetic etiologies associated with infantile
central hypotonia are Pelizaeus-Merzbacher Allan-
Herndon-Dudley, Coffin-Lowry, Lowe, alpha thalas-
semia, and MECP2 spectrum disorders such as Rett
syndrome and MECP2 duplication at Xq28 [26]. Treat-
ment for infantile central hypotonia is massive supportive
and symptomatic care. In our study, Patient 1 was treated
in the neonatal intensive care unit due to infantile central
hypotonia with poor sucking. If a genetic study was
carried out at that time of his birth, he could have been
diagnosed. We suggest that infantile central hypotonia pa-
tients must be considered for testing for Xq28 duplication
syndrome, particularly duplication atMECP2.
Several children with duplicated MECP2 and IRAK1
were reported to have suffered severe recurrent respiratory
infections with decreased IgA levels and poor antibody re-
sponses due to polysaccharide antigens exhibited in some
children [26]. Even though Patient 2 had severe recurrent
respiratory infections requiring hospitalization thrice a
year, there was no evidence of immunodeficiency as per
our assessment of complement and Ig antibodies. In a pre-
vious study, patients with overexpressed MECP2 were par-
tially immunodeficient possibly due to the overexpression
ofMECP2 suppressing interferon (IFN)-γ secretion from T
helper cells [27]. The intermediate signaling molecule,
IRAK1, is known to have a critical roles in the Toll-like
receptor (TLR) signaling pathway and activation and regu-
lation of innate and adaptive immunity [28, 29]. Thus,
cellular immune dysfunction, due in part to the suppres-
sion of IFN-γ production from T helper cells, is potentially
caused by overexpression of MECP2 and IRAK1 in Xq28
duplication syndrome. However, additional studies for
humoral immune dysfunction in Xq28 duplication are
required.
Females rarely display the canonical neurological pheno-
types including intellectual disability, associated with
MECP2 duplication is due to extreme (>80%) or complete
(100%) skewed XCI [30, 31]. The Mother of Patients 1 and
2 had the same duplication profile as her son. However,
she had completely skewed (100%) XCI, including the du-
plicated MECP2 region, and she significantly little neuro-
logical manifestations as compared to her sons. Female
patients carrying MECP2 mutations in Rett syndrome dis-
play X-linked dominant inheritance and not skewed XCI.
However, female carriers with MECP2 duplication exhibit
X-linked recessive inheritance and skewed XCI. This im-
plies that overexpression of the neighboring genes in the
duplicated Xq28 region rather than MECP2 itself causes
negative selection, leading to XCI during the early embry-
onic period [32]. Mayo et al. specifically noted that the
arrest-defective protein 1 homolog A (ARD1A or NAA10;
MIM *300013) and host cell factor C1 (HCFC1; MIM
*300019) as genes responsible for induced preferential XCI
in females [33]. In our study the Mother had duplication
in parts of NAA10 and HCFC1, and thus the possibility of
negative selection was considered. In prior studies, obvious
clinical phenotypes of MECP2 duplication syndrome was
reported in females with less than 70% skewed XCI
[31, 34–36]. Additional research on the mechanism of
XCI is needed, especially since negative selection may
not occur despite the duplication of NAA1 and HCFC1.
Further studies dissecting the genotype-phenotype correl-
ation against the degree of MECP2 expression are also
required.
Conclusions
MECP2/IRAK1 duplication at Xq28 is inherited as an
X-linked recessive trait and male-specific disorder as-
sociated with severe intellectual disability. MECP2/
IRAK1 was associated with primary dose-sensitive and
dose-critical gene for the neurological phenotypes.
Carrier mother had mild neuropsychiatric symptoms
despite of markedly skewed XCI. Additional research
is needed to know the relationship between neuropsychi-
atric phenotype and degree of MECP2 expression.
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